Akeso, Inc. (HKG:9926)
Hong Kong
· Delayed Price · Currency is HKD 114.90
+11.20 (10.80%)
Mar 10, 2026, 2:04 PM HKT
Akeso Revenue
Akeso had revenue of 1.41B CNY in the half year ending June 30, 2025, a decrease of -61.61%. This brings the company's revenue in the last twelve months to 2.51B, up 33.97% year-over-year. In the year 2024, Akeso had annual revenue of 2.12B, down -53.08%.
Revenue (ttm)
2.51B CNY
Revenue Growth
+33.97%
P/S Ratio
34.72
Revenue / Employee
711.46K CNY
Employees
3,529
Market Cap
95.52B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sichuan Kelun-Biotech Biopharmaceutical | 1.64B |
| Sino Biopharmaceutical | 33.49B |
| Innovent Biologics | 12.52B |
| WuXi Biologics | 21.98B |
| RemeGen | 3.62B |
| 3SBio | 9.94B |
| Shanghai Henlius Biotech | 6.35B |
| BeOne Medicines AG | 41.59B |